[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1985

Progression of Visual Field Defects in GlaucomaRelation to Compliance With Pilocarpine Therapy

Author Affiliations

From the Department of Ophthalmology, Huddinge (Sweden) University Hospital and Karolinska Institute, Stockholm.

Arch Ophthalmol. 1985;103(4):529-531. doi:10.1001/archopht.1985.01050040071020
Abstract

• In patients with primary open-angle glaucoma, compliance with pilocarpine therapy was studied with an electronic medication monitor. The visual fields and intraocular pressure (IOP) readings were followed up retrospectively during two years before and two years after the compliance measurements. Progression of visual field defects was significantly more common in patients with capsular glaucoma than in patients with simple glaucoma. Eyes with more extensive visual field defects showed progression more often than did eyes with smaller defects, and so did eyes with a high mean IOP as compared with those with a low mean IOP. Visual field defect progression was not significantly more common among patients with "poor" than among patients with "good" compliance, which indicates that noncompliance is less important for the outcome than are the type of glaucoma, the stage of visual field defects, and the mean IOP.

References
1.
Dixon WM, Stradling P, Wootton ID:  Outpatient PAS therapy . Lancet 1957;2:871-872.Article
2.
Sackett DL, Haynes RB, Gibson ES, et al:  Randomized clinical trial of strategies for improving medication compliance in primary hypertension . Lancet 1975;1:1205-1207.Article
3.
Johnston GD, Kelly JG, McDevitt DG:  Do patients take digoxin? Br Heart J 1978;40:1-7.Article
4.
Stewart RB, Cluff LE:  A review of medication errors and compliance in ambulant patients . Clin Pharmacol Ther 1972;13:463-468.
5.
Kass MA, Kolker AE, Becker B:  Prognostic factors in glaucomatous visual field loss . Arch Ophthalmol 1976;94:1274-1276.Article
6.
Olivius E, Thorburn W:  Prognosis of glaucoma simplex and glaucoma capsulare . Acta Ophthalmol 1978;56:921-934.Article
7.
Armaly MF, Krueger DE, Maunder L, et al:  Biostatistical analysis of the collaborative glaucoma study: I. Summary report of the risk factors for the glaucomatous visual field defects . Arch Ophthalmol 1980;98:2163-2171.Article
8.
Wilson R, Walker AM, Dueker DK, et al:  Risk factors for rate of progression of glaucomatous visual field defects . Arch Ophthalmol 1982; 100:737-741.Article
9.
Kass MA:  Noncompliance to ocular therapy . Ann Ophthalmol 1978;10:1244-1245.
10.
Norell S, Granström P-A:  Do glaucoma patients take their pilocarpine eye drops? Acta Ophthalmol 1978;56:477-478.
11.
Norell SE:  Medication behaviour: A study of outpatients treated with pilocarpine eye drops for primary open-angle glaucoma . Acta Ophthalmol 1980;58( (suppl 143) ):1-28.
12.
Alward PD, Wilensky JT:  Determination of acetazolamide compliance in patients with glaucoma . Arch Ophthalmol 1981;99:1973-1976.Article
13.
Granström P-A:  Glaucoma patients not compliant with their drug therapy: Clinical and behavioural aspects . Br J Ophthalmol 1982; 66:464-470.Article
14.
Kass MA, Meltzer DW, Gordon MO:  Compliance to topical pilocarpine therapy , abstracted. Invest Ophthalmol Vis Sci 1983;24( (suppl 3) ):166.
15.
Norell S, Granström P-A, Wassen R:  A medication monitor and fluorescein technique designed to study medication behaviour . Acta Ophthalmol 1980;58:459-467.Article
16.
Rock WJ, Drance SM, Morgan RW:  A modification of the Armaly visual field screening technique for glaucoma . Can J Ophthalmol 1971; 6:283-292.
17.
Dixon WJ, Massey FJ: Introduction to Statistical Analysis , ed 3. New York, McGraw-Hill Book Co, 1969, pp 184-187.
18.
Norell SE:  Accuracy of patient interviews and estimates by clinical staff in determining medication compliance . Soc Sci Med 1981;15:57-61.Article
19.
Norell SE:  Methods in assessing drug compliance . Acta Med Scand , 1984, (suppl 683) , pp 35-40.
20.
Norell SE:  Monitoring compliance with pilocarpine therapy . Am J Ophthalmol 1981; 92:727-731.
×